Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)

0.5179 -0.0221 (-4.09%)
Streaming Delayed Price Updated: 3:31 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TransCode Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
TransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update
From TransCode Therapeutics, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 46 stocks hit new 52-week lows. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning! 
Via InvestorPlace
TransCode Therapeutics Announces Positive Results in Non-human Primates with its Lead Therapeutic Candidate, TTX-MC138
Further Supporting TTX-MC138 Application in Metastatic Cancer 
From TransCode Therapeutics, Inc.
Via GlobeNewswire
Stonegate Healthcare Partners Announces Publishing of a Thematic Report - The RNA Revolution: Unleashing the Therapeutic Potential of RNAi
Dallas, Texas--(Newsfile Corp. - July 13, 2023) - Stonegate Healthcare Partners (SHP), a healthcare strategy consulting firm, is pleased to... 
Via Newsfile
TransCode Therapeutics CEO Letter to Shareholders
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
Via Benzinga
TransCode Therapeutics Announces Publication of New Data Supporting the Use of TTX-MC138 for the Treatment of Metastatic Breast Cancer
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
The Dow Jones closed higher by over 140 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 32 companies reached new 52-week lows. 
Via Benzinga
TransCode Therapeutics Announces Closing of $7 Million Public Offering
From TransCode Therapeutics, Inc.
Via GlobeNewswire
Why Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) shares climbed 91.2% to $10.81. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 35 stocks hit new 52-week lows. 
Via Benzinga
Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 50.5% to $0.20 in pre-market trading after dropping 5% on Wednesday. 
Via Benzinga
Why TransCode Therapeutics Stock Is Trading Higher Premarket Today
TransCode Therapeutics Inc (NASDAQ: RNAZ) announced acceptance for publication by Frontiers in Molecular Biosciences of a preclinical study using TransCode's lead therapeutic candidate, TTX-MC138, in  
Via Benzinga
Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Tesla, Coinbase, Transcode Therapeutics, Boeing, Yext: Why These 5 Stocks Are Drawing Investor Attention
Via Benzinga
TransCode Therapeutics Announces Pricing of $7 Million Public Offering
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Glioblastoma
Study provides support for further evaluation of TransCode’s lead therapeutic candidate, TTX-MC138, in clinical trials 
From TransCode Therapeutics, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
TransCode Therapeutics Announces 1-for-20 Reverse Stock Split
From TransCode Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
TransCode Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial
From TransCode Therapeutics, Inc.
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
TransCode Therapeutics Announces Strategic Expansion of its Product Portfolio
Submits Provisional Patent Application entitled “Nanoparticles Comprising Payloads and Their In Vivo Delivery.” 
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics Announces Equity Investment from White Lion Capital to Help Fund Development of TTX-MC138 for Treatment of Glioblastomas
From TransCode Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.